Back to results
CompletedPhase 4

Glycemic Control of Biphasic Insulin Aspart 30 in Type 2 Diabetes

NCT01697631

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Novo Nordisk Investigational Site

Bialystok, Poland

+11 additional locations

View on ClinicalTrials.gov
Glycemic Control of Biphasic Insulin Aspart 30 in Type 2 Diabetes — TrialFind